First Squawk
@FirstSquawk
Firstsquawk Is a Global Financial (News) Squawk Service Specialising In Financial Markets, Macro, Geopolitics,politics
Joined July 2015
252 Following 578K Followers
ELI LILLY SAYS THE TRIPLE AGONIST ALSO REDUCED A1C IN PEOPLE WITH OBESITY AND TYPE 2 DIABETES, WITH A BIOLOGICS LICENCE APPLICATION PLANNED FOR Q1 2027.
